Improved postprandial glycemic control with humalog® mix75/25™ after a standard test meal in patients with type 2 diabetes mellitus

This publication has 11 references indexed in Scilit:

• Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.
  Diabetes Care, 1999
• Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mix25 and insulin lispro Mix50
  Clinical Therapeutics, 1999
• Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
  Diabetes Care, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• The human insulin analogue insulin lispro.
  Annals of Medicine, 1998
• Nighttime Insulin Kinetics and Glycemic Control in Type 1 Diabetes Patients Following Administration of an Intermediate-Acting Lispro Preparation
  Diabetes Care, 1997
• Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group
  Archives of internal medicine (1960), 1997
• Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group
  Diabetes, 1997
• Dosage accuracy of self-mixed vs premixed insulin
  Archives of internal medicine (1960), 1991
• The Two Period Binary Response Cross‐Over Trial
  Biometrical Journal, 1986